Gui‐Fa Su

1.8k total citations
85 papers, 1.5k citations indexed

About

Gui‐Fa Su is a scholar working on Organic Chemistry, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Gui‐Fa Su has authored 85 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Organic Chemistry, 22 papers in Molecular Biology and 7 papers in Pharmaceutical Science. Recurrent topics in Gui‐Fa Su's work include Catalytic C–H Functionalization Methods (39 papers), Quinazolinone synthesis and applications (16 papers) and Cyclopropane Reaction Mechanisms (12 papers). Gui‐Fa Su is often cited by papers focused on Catalytic C–H Functionalization Methods (39 papers), Quinazolinone synthesis and applications (16 papers) and Cyclopropane Reaction Mechanisms (12 papers). Gui‐Fa Su collaborates with scholars based in China, Iran and United States. Gui‐Fa Su's co-authors include Dong‐Liang Mo, Cheng‐Xue Pan, Cui Liang, Xiao‐Pan Ma, Jiang‐Ke Qin, Jing‐Mei Yuan, Guohai Zhang, Feng Yu, Siyi Wu and Chenxi Gu and has published in prestigious journals such as Angewandte Chemie International Edition, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Gui‐Fa Su

78 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gui‐Fa Su China 25 1.2k 370 87 84 70 85 1.5k
Justin M. Lopchuk United States 13 804 0.7× 387 1.0× 92 1.1× 85 1.0× 33 0.5× 26 1.2k
Kamyar Afarinkia United Kingdom 18 1.2k 1.0× 349 0.9× 62 0.7× 150 1.8× 55 0.8× 73 1.4k
Moncef Msaddek Tunisia 16 694 0.6× 245 0.7× 48 0.6× 57 0.7× 49 0.7× 81 868
Adam Daı̈ch France 24 1.5k 1.3× 498 1.3× 32 0.4× 108 1.3× 92 1.3× 136 1.8k
María Dolors Pujol Spain 20 952 0.8× 485 1.3× 36 0.4× 60 0.7× 58 0.8× 93 1.3k
Sheng‐Jiao Yan China 26 1.7k 1.4× 287 0.8× 165 1.9× 67 0.8× 30 0.4× 109 1.9k
H. Ali Döndaş Türkiye 21 997 0.8× 250 0.7× 74 0.9× 98 1.2× 53 0.8× 79 1.2k
Benoı̂t Rigo France 22 1.5k 1.2× 638 1.7× 32 0.4× 119 1.4× 79 1.1× 149 1.8k
Kempegowda Mantelingu India 22 1.1k 0.9× 702 1.9× 25 0.3× 78 0.9× 135 1.9× 110 1.7k

Countries citing papers authored by Gui‐Fa Su

Since Specialization
Citations

This map shows the geographic impact of Gui‐Fa Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gui‐Fa Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gui‐Fa Su more than expected).

Fields of papers citing papers by Gui‐Fa Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gui‐Fa Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gui‐Fa Su. The network helps show where Gui‐Fa Su may publish in the future.

Co-authorship network of co-authors of Gui‐Fa Su

This figure shows the co-authorship network connecting the top 25 collaborators of Gui‐Fa Su. A scholar is included among the top collaborators of Gui‐Fa Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gui‐Fa Su. Gui‐Fa Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Chen, Shan, et al.. (2025). Bis(pinacolato)diborane Promoted Selective Transfer Hydrogenation of Alkynes to Prepare Alkanes. Chinese Journal of Chemistry. 43(24). 3603–3609.
4.
Zheng, Bin, Yixiao Wang, Ziyan Wu, et al.. (2025). Design, Synthesis and Bioactive Evaluation of Topo I/c-MYC Dual Inhibitors to Inhibit Oral Cancer via Regulating the PI3K/AKT/NF-κB Signaling Pathway. Molecules. 30(4). 894–894. 1 indexed citations
5.
Su, Jun‐Cheng, et al.. (2024). Synthesis of 4-(trichloromethyl)pyrido[2′,1′:3,4]pyrazino[2,1-b]quinazolinones through a cyclized dearomatization and trichloromethylation cascade strategy. Organic & Biomolecular Chemistry. 22(7). 1386–1390. 1 indexed citations
6.
Sun, Jiayi, Xinwei Li, Wang Wang, et al.. (2023). Design and synthesis of pseudo-rutaecarpines as potent anti-inflammatory agents via regulating MAPK/NF-κB pathways to relieve inflammation-induced acute liver injury in mice. Bioorganic Chemistry. 138. 106611–106611. 6 indexed citations
7.
Chen, Yin, M. Iqbal Choudhary, Ying‐Ming Pan, et al.. (2022). One-pot synthesis of oxoaporphines as potent antitumor agents and investigation of their mechanisms of actions. European Journal of Medicinal Chemistry. 231. 114141–114141. 8 indexed citations
8.
Lu, Ke, Jing‐Mei Yuan, Xiaojuan Li, et al.. (2021). 3-Arylamino-quinoxaline-2-carboxamides inhibit the PI3K/Akt/mTOR signaling pathways to activate P53 and induce apoptosis. Bioorganic Chemistry. 114. 105101–105101. 9 indexed citations
9.
Li, Wenxiu, Hua Chen, Jun Li, et al.. (2019). Inhibitor structure-guided design and synthesis of near-infrared fluorescent probes for monoamine oxidase A (MAO-A) and its application in living cells and in vivo. Chemical Communications. 55(17). 2477–2480. 41 indexed citations
10.
Liu, Qingqing, Ke Lu, Jing‐Mei Yuan, et al.. (2019). Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo. European Journal of Medicinal Chemistry. 165. 293–308. 44 indexed citations
11.
Wei, Xinwei, Jing‐Mei Yuan, Wan‐Yun Huang, et al.. (2019). 2-Styryl-4-aminoquinazoline derivatives as potent DNA-cleavage, p53-activation and in vivo effective anticancer agents. European Journal of Medicinal Chemistry. 186. 111851–111851. 34 indexed citations
12.
Yuan, Jing‐Mei, Guohai Zhang, Xinwei Wei, et al.. (2019). Cryptolepine and aromathecin based mimics as potent G-quadruplex-binding, DNA-cleavage and anticancer agents: Design, synthesis and DNA targeting-induced apoptosis. European Journal of Medicinal Chemistry. 169. 144–158. 25 indexed citations
13.
Wang, Zhixin, et al.. (2017). Synthesis of 1‐Vinyl/Arylbenzotriazole 3‐Oxides through a Copper‐Mediated C–N Bond Coupling Reaction. Advanced Synthesis & Catalysis. 359(16). 2741–2746. 18 indexed citations
15.
Chen, Zhengjun, Wei Hu, Mian Wang, et al.. (2016). Synthesis and evaluation of a water-solubility glycosyl-rhodamine fluorescent probe detecting Hg2+. Carbohydrate Research. 429. 81–86. 11 indexed citations
16.
Zhang, Guohai, et al.. (2015). Distinct novel quinazolinone exhibits selective inhibition in MGC-803 cancer cells by dictating mutant p53 function. European Journal of Medicinal Chemistry. 95. 377–387. 32 indexed citations
17.
Huang, Jun, et al.. (2014). Design, synthesis and biological evaluation of novel 1-hydroxyl-3-aminoalkoxy xanthone derivatives as potent anticancer agents. European Journal of Medicinal Chemistry. 85. 487–497. 23 indexed citations
18.
Su, Gui‐Fa, Zhongchang Wang, Wan‐Yun Huang, Zhixin Wang, & Zilu Chen. (2009). (Z)-Isobutyl 2-benzamido-3-(4-chlorophenyl)acrylate. Acta Crystallographica Section E Structure Reports Online. 65(11). o2890–o2890. 1 indexed citations
19.
Pakhomov, Serhii, et al.. (2007). Water Soluble Metallo-Phthalocyanines: The Role of the Functional Groups on the Spectral and Photophysical Properties. Journal of Fluorescence. 17(5). 547–563. 34 indexed citations
20.
Su, Gui‐Fa, et al.. (2002). A NEW AND RAPID N -ALKYLATION OF 3,6-EPOXY-HEXAHYDROPHTHALIMIDES. Synthetic Communications. 32(3). 381–385.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026